AUS
NZ
UK
CA
USA
IND
Healthcare
Top Healthcare Stocks to Watch: Why Pro (ASX:PME) Is Leading a New Market Conversation
July 06, 2026 09:45 PM AEST| By SamHealthcare stocks are attracting renewed attention as markets increasingly prioritise workflow efficiency, recurring revenue and hospital technology adoption, with Pro Medicus, ResMed, Neuren Pharmaceuticals and Sonic Healthcare illustrating the sect...
Why Is CSL (ASX:CSL) Leading the Healthcare Revival on the ASX?
July 06, 2026 04:46 PM AEST| By SamCSL has returned to the spotlight as healthcare stocks regain momentum, with sector-wide rotation, global healthcare exposure and upcoming operational updates shaping attention across Australia's leading healthcare companies.
Why Is Pro Medicus (ASX:PME) Driving the ASX Healthcare Revival?
July 06, 2026 01:23 PM AEST| By SamPro Medicus strengthened its market position through new US healthcare contracts and the Echo IQ partnership as renewed momentum across Australia's healthcare sector continues supporting commercial technology leaders.
Is 4DMedical (ASX:4DX) Still Undervalued After Its TGA Approval?
July 06, 2026 10:29 AM AEST| By Sam4DMedical has strengthened its commercial outlook through TGA approval for its CT:VQ imaging software, highlighting growing innovation across artificial intelligence, digital diagnostics and Australia's healthcare technology industry.
Why Is CSL (ASX:CSL) Driving the ASX 200 Healthcare Revival?
July 06, 2026 03:55 AM AEST| By SamHealthcare shares have regained market leadership as CSL, Pro Medicus, Telix Pharmaceuticals and other leading companies drive a broad sector recovery supported by improving sentiment and resilient business fundamentals.
Is Sonic Healthcare's Valuation Telling a Different Story in 2026?
July 04, 2026 07:00 PM AEST| By SamSonic Healthcare's valuation has returned to focus as markets assess revenue resilience, profitability and long-term healthcare demand, highlighting the importance of diversified diagnostics businesses across international healthcare markets.
Why Is Pro Medicus (ASX:PME) Dominating Medical Imaging Software?
July 03, 2026 06:42 PM AEST| By SamPro Medicus continues expanding its medical imaging software business through growing hospital adoption, reinforcing its position as one of Australia's leading healthcare technology companies.
Why Healthcare Stocks Are Back In Focus As Rebound Quality Test Takes Over
July 03, 2026 06:27 PM AEST| By SamAustralia's healthcare sector is back in focus as markets increasingly reward earnings quality, resilient business models and disciplined execution, with CSL, ResMed, Pro Medicus and Cochlear highlighting the sector's evolving leadership.
Top Healthcare Stocks to Watch: Sonic Healthcare (ASX:SHL) Leads the Defensive Shift
July 03, 2026 06:26 PM AEST| By SamAustralia's healthcare sector is drawing renewed attention as diagnostics, hospitals, insurers and medical technology companies are increasingly assessed on resilient earnings, financial discipline and operational quality within a more selective mark...
Can ResMed (ASX:RMD) and Pro Medicus Lead the Next Growth Revival?
July 03, 2026 03:45 PM AEST| By SamHealthcare has re-emerged as a leading market theme as Australian investors focus on quality businesses with resilient earnings, disciplined balance sheets and consistent execution, placing ResMed, Pro Medicus, CSL and Cochlear firmly in focus.
Mesoblast (ASX:MSB): Why Is ASX 200 Watching Its Cell Therapy Milestone?
July 03, 2026 03:45 PM AEST| By SamMesoblast has entered an important stage of its regenerative medicine program after strengthening funding and completing enrolment for its pivotal chronic back pain clinical study.
CSL (ASX:CSL): Why Is ASX 200 Healthcare Rebounding With Telix And Pro Medicus?
July 03, 2026 11:41 AM AEST| By SamAustralia's healthcare sector regained momentum as CSL, Telix Pharmaceuticals and Pro Medicus strengthened market sentiment through biotechnology, precision medicine and healthcare technology leadership.
Could Ramsay Health Care (ASX:RHC) Unlock More Value Through Its European Restructure?
July 03, 2026 11:06 AM AEST| By SamRamsay Health Care is attracting renewed attention as its European restructuring plans progress alongside improving operational performance and continued healthcare demand.
Could OncoSil Medical (ASX:OSL) Be Nearing Its Biggest Regulatory Milestone Yet?
July 03, 2026 10:14 AM AEST| By SamOncoSil Medical has entered the formal FDA review stage after completing its US application submission, marking another significant milestone in its international commercial expansion strategy.
ASX Healthcare Stocks Face a New Confidence Test: Is the Recovery Real?
July 02, 2026 10:26 PM AEST| By SamAustralia's healthcare sector is regaining attention as markets become more selective. Companies are increasingly assessed on execution, resilience and business quality, making healthcare a sector worth watching beyond short-term market sentiment.
Cochlear (ASX:COH) and Diagnostics Volumes Spark a Fresh Healthcare Shift
July 02, 2026 09:54 PM AEST| By SamHealthcare stocks are returning to focus as diagnostics volumes, patient activity and company execution become increasingly important in shaping market sentiment across Australia's healthcare sector.
Why Is Halma (LSE:HLMA) Expanding Its Healthcare Portfolio With New Acquisitions?
July 02, 2026 06:27 PM AEST| By Vivek SinghDiscover why Halma (LSE:HLMA) has expanded its healthcare portfolio through strategic acquisitions, enhancing hospital software solutions and cancer treatment technologies while strengthening its global healthcare presence.
Why Is CSL (ASX:CSL) Back on Watchlists Across the ASX 200?
July 02, 2026 03:40 PM AEST| By SamCSL has returned to market focus as resilient healthcare demand, diversified biotechnology operations and long-term medical trends reinforce the importance of Australia's healthcare sector.
ResMed (ASX:RMD): Why Is Healthcare Software Standing Out?
July 02, 2026 02:20 PM AEST| By SamHealthcare stocks are gaining fresh ASX attention as ResMed, Sonic Healthcare, Pro Medicus, CSL and Cochlear highlight medical software, diagnostics and connected care themes.
Cochlear (ASX:COH): Why Are Healthcare Stocks Rebuilding Trust?
July 02, 2026 01:20 PM AEST| By SamHealthcare stocks are attracting renewed ASX attention as Cochlear, ResMed, CSL, Sonic Healthcare and Pro Medicus highlight business quality, innovation and operational resilience.
Advertise your brand on Kalkine Media